Vancouver’s Precision NanoSystems announced today the location of its new Genetic Medicine GMP Biomanufacturing Center in Vancouver. Precision NanoSystems will expand its global headquarters with a 75,000-square-foot facility currently under construction and slated for completion in Q4 2022. The new site will be located at 1055 Vernon Drive, in the Evolution Block building, in the […]
Precision Nanosystems
Precision NanoSystems Acquired By Danaher And Vancouver Manufacturing Centre Still In The Works
Vancouver’s Precision NanoSystems has been acquired by Danaher Corporation’s Life Sciences platform. PNI will join Danaher’s Life Sciences platform and will be complementary to other businesses in the platform, including Cytiva and Pall. PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer and rare diseases, including […]
11 B.C. Tech Companies Named To 2021 Narwhal List
The Narwhal Project identifies a set of young Canadian companies that have the potential to become successful on the world stage. The Narwhal List sheds light on the ability of firms to scale up and reach world-class status. 2020 was another remarkable year for Canadian Narwhals and eleven companies from B.C. made the cut. The […]
Precision NanoSystems Receives $25 Million To Build RNA Medicine Biomanufacturing Centre
Vancouver’s Precision NanoSystems announced today that it has received a contribution of $25.1 million through the Strategic Innovation Fund (SIF). This contribution will support a $50.2-million project to establish a biomanufacturing centre in Vancouver dedicated to the production of ribonucleic acid (RNA) lipid nanoparticle vaccines and genetic medicines. The centre will support the Government of Canada’s national biomanufacturing strategy to […]
Precision NanoSystems Receives $18.2 Million To Develop COVID-19 Vaccine
Vancouver’s Precision Nanosystems has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development’s (ISED) Strategic Innovation Fund (SIF) to develop a COVID-19 vaccine. Bringing together its proprietary technology platforms, key partnerships and unparalleled expertise in nanomedicines, Precision Nanosystems (PNI) will use the […]